Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of  -synuclein in Parkinson's disease models

Michaeline Hebron(Georgetown University), Charbel Moussa(Georgetown University)
Human Molecular Genetics
May 10, 2013
Cited by 325


Related Papers